nach oben

Erschienen in:

27.07.2020 | IM - ORIGINAL

Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

verfasst von: Christiano Argano, Nicola Scichilone, Giuseppe Natoli, Alessandro Nobili, Gino Roberto Corazza, Pier Mannuccio Mannucci, Francesco Perticone, Salvatore Corrao, on behalf of the REPOSI Investigators

Erschienen in: Internal and Emergency Medicine | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Currently, chronic obstructive pulmonary disease (COPD) represents the fourth cause of death worldwide with significant economic burden. Comorbidities increase in number and severity with age and are identified as important determinants that influence the prognosis. In this observational study, we retrospectively analyzed data collected from the RePoSI register. We aimed to investigate comorbidities and outcomes in a cohort of hospitalized elderly patients with the clinical diagnosis of COPD. Socio-demographic, clinical characteristics and laboratory findings were considered. The association between variables and in-hospital, 3-month and 1-year follow-up were analyzed. Among 4696 in-patients, 932 (19.8%) had a diagnosis of COPD. Patients with COPD had more hospitalization, a significant overt cognitive impairment, a clinically significant disability and more depression in comparison with non-COPD subjects. COPD patients took more drugs, both at admission, in-hospital stay, discharge and 3-month and 1-year follow-up. 14 comorbidities were more frequent in COPD patients. Cerebrovascular disease was an independent predictor of in-hospital mortality. At 3-month follow-up, male sex and hepatic cirrhosis were independently associated with mortality. ICS-LABA therapy was predictor of mortality at in-hospital, 3-month and 1-year follow-up. This analysis showed the severity of impact of COPD and its comorbidities in the real life of internal medicine and geriatric wards.

Nur mit Berechtigung zugänglich

Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3:e442PubMedPubMedCentral

Fabbri LM, Luppi F, Beghe B et al (2008) Complex chronic comorbidities of COPD. Eur Respir J 31:204–212PubMed

Agusti A, Calverley PM, Celli B et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122PubMedPubMedCentral

Cavaillès A, Brinchault-Rabin G, Dixmier A et al (2013) Comorbidities of COPD. Eur Respir Rev 22:454–475PubMed

Divo M, Cote C, de Torres JP, BODE Collaborative Group et al (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186(2):155–161PubMed

Battaglia S, Basile M, Spatafora M et al (2015) Are asthmatics enrolled in randomized trials representative of real-life outpatients? Respiration 89:383–389PubMed

Scichilone N, Basile M, Battaglia S et al (2014) What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials? Respiration 87(1):11–17PubMed

The REPOSI registry of multimorbidity and polypharmacy: http://www.reposi.org. Accessed 12 Dec 2018

Katzman R, Brown T, Fuld P et al (1983) Validation of a short Orientation–Memory–Concentration Test of cognitive impairment. Am J Psychiatry 140:734–739PubMed

10.

Hickie C, Snowdon J (1987) Depression scales for the elderly: gDS, Gilleard, Zung. Clin Gerontol J Aging Ment Health. 6:51–53

11.

Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J. 14:61–65PubMed

12.

Linn BS, Linn MW, Gurel L (1968) Cumulative illness rating scale. J Am Geriatr Soc 16:622–626PubMed

13.

Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med. 150:604–612PubMedPubMedCentral

14.

Hosmer DW, Lemeshow S (2000) Multiple logistic regression. In: Hosmer DW, Lemeshow S (eds) Applied logistic regression, 2nd edn. J Wiley; New York, NY, pp 31–46

15.

Aramburu A, Arostegui I, Moraza J et al (2019) COPD classification models and mortality prediction capacity. Int J Chron Obstruct Pulmon Dis. 14:605–613PubMedPubMedCentral

16.

Yin HL, Yin SQ, Lin QY et al (2017) Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine 96(19):e6836PubMedPubMedCentral

17.

Almagro P, Cabrera FJ, Diez J, Working Group on, COPD, Spanish Society of Internal Medicine et al (2012) Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 142(5):1126–1133PubMed

18.

Bloom CI, Ricciardi F, Smeeth L, Stone P, Quint JK (2019) Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care. BMC Med. 17(1):73PubMedPubMedCentral

19.

Corrao S, Santalucia P, Argano C, REPOSI Investigators et al (2014) Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study. Eur J Intern Med 25(7):617–623PubMed

20.

Zewari S, Vos P, van den Elshout F et al (2017) Obesity in COPD: revealed and Unrevealed Issues. COPD 14(6):663–673PubMed

21.

Schnell K, Weiss CO, Lee T et al (2012) The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 12:26PubMedPubMedCentral

22.

Schane RE, Walter LC, Dinno A et al (2008) Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 23(11):1757–1762PubMedPubMedCentral

23.

Dodd JW, Charlton RA, van den Broek MD et al (2013) Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest 144(1):119–127PubMed

24.

Yohannes AM, Chen W, Moga AM et al (2017) Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta-analysis of observational studies. J Am Med Dir Assoc. 18(5):e1–451

25.

Hanania NA, Sharma G, Sharafkhaneh A (2010) COPD in the elderly patient. Semin Respir Crit Care Med 31(5):596–606PubMed

26.

Fried LP, Bandeen-Roche K, Kasper JD et al (1999) Association of comorbidity with disability in older women: the Women’s Health and Aging Study. J Clin Epidemiol 52(1):27–37PubMed

27.

García-Pérez L, Linertová R, Lorenzo-Riera A et al (2011) Risk factors for hospital readmissions in elderly patients: a systematic review. QJM 104:639–651PubMed

28.

Corrao S, Natoli G, Nobili A, RePoSI Investigators et al (2019) Comorbidity does not mean clinical complexity: evidence from the RePoSI register. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02211-3CrossRefPubMed

29.

Ozyilmaz E, Kokturk N, Teksut G et al (2013) Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease. Int J Clin Pract 67(7):691–697PubMed

30.

Ershler WB, Chen K, Reyes EB et al (2005) Economic burden of patients with anemia in selected diseases. Value Health. 8(6):629–638PubMed

31.

Cote C, Zilberberg MD, Mody SH et al (2007) Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 29(5):923–929PubMed

32.

Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352(10):1011–1023PubMed

33.

Corrao S, Argano C, Natoli G, REPOSI Investigators et al (2018) Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia. Eur J Intern Med. 54:53–59PubMed

34.

Lanièce I, Couturier P, Dramé M et al (2008) Incidence and main factors associated with early unplanned hospital readmission among French medical inpatients aged 75 and over admitted through emergency units. Age Ageing 37(4):416–422PubMed

35.

Lohman MC, Scherer EA, Whiteman KL et al (2018) Factors Associated With Accelerated Hospitalization and Re-hospitalization Among Medicare Home Health Patients. J Gerontol A Biol Sci Med Sci 73(9):1280–1286PubMed

36.

Wang Y, Stavem K, Dahl FA et al (2014) Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis. 9:99–105PubMedPubMedCentral

37.

Barabási AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12(1):56–68PubMedPubMedCentral

38.

Fabbri LM, Rabe KF (2007) From COPD to chronic systemic inflammatory syndrome? Lancet 370(9589):797–799PubMed

39.

Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. Suppl 1:S4–S9

40.

Miller J, Edwards LD, Agustí A, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators et al (2013) Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 107(9):1376–1384PubMed

41.

Thomsen M, Dahl M, Lange P et al (2012) Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186(10):982–988PubMed

42.

Agustí A, Edwards LD, Rennard SI, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators et al (2012) Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 7(5):e37483PubMedPubMedCentral

43.

Vanfleteren LE, Spruit MA, Groenen M et al (2013) Clusters of Comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187(7):728–735PubMed

44.

Kim YR, Hwang IC, Lee YJ et al (2018) Stroke risk among patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Clinics. 73:e177PubMedPubMedCentral

45.

Baty F, Putora PM, Isenring B et al (2013) Comorbidities and burden of COPD: a population-based case-control study. PLoS ONE 8(5):e63285PubMedPubMedCentral

46.

Sundh J, Ställberg B, Lisspers K et al (2011) Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD 8(3):173–181PubMed

47.

Mannino DM, Higuchi K, Yu TC et al (2015) Economic burden of COPD in the presence of comorbidities. Chest 148:138–150PubMedPubMedCentral

48.

Horita N, Goto A, Shibata Y et al (2017) Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2:CD012066PubMed

49.

Ernst P, Saad N, Suissa S (2015) Inhaled corticosteroids in COPD: the clinical evidence. Eur Respir J 45(2):525–537PubMed

50.

Simonetti AF, Viasus D, Garcia-Vidal C et al (2014) Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis 2(1):3–16PubMedPubMedCentral

51.

Vitacca M, Paneroni M, Baiardi P et al (2016) Development of a Barthel Index based on dyspnea for patients with respiratory diseases. International Journal of Chronic Obstructive Pulmonary Disease. 11:1199–1206PubMedPubMedCentral

52.

Formiga F, Ferrer A, Padros G et al (2016) Evidence of functional declining and global comorbidity measured at baseline proved to be the strongest predictors for long-term death in elderly community residents aged 85 years: a 5-year follow-up evaluation, the OCTABAIX study. Clin Interv Aging 11:437–444PubMedPubMedCentral

53.

Singanayagam A, Schembri S, Chalmers JD (2013) Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10(2):81–89PubMed

54.

Mapel D (2014) Renal and hepatobiliary dysfunction in chronic obstructive pulmonary disease. Curr Opin Pulm Med 20(2):186–193PubMed

55.

Satish S, Freeman DH Jr, Ray L, Goodwin JS (2001) The relationship between blood pressure and mortality in the oldest old. J Am Geriatr Soc 49(4):367–374PubMed

56.

Odden MC, Peralta CA, Haan MN et al (2012) Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med 172:1162–1168PubMedPubMedCentral

57.

Zhang XE, Cheng B, Wang Q (2016) Relationship between high blood pressure and cardiovascular outcomes in elderly frail patients: a systematic review and meta-analysis. Geriatr Nurs. 37(5):385–392PubMed

58.

Post Hospers G, Smulders YM, Maier AB, Deeg DJ, Muller M (2015) Relation between blood pressure and mortality risk in an older population: role of chronological and biological age. J Intern Med 277(4):488–497PubMed

59.

Corrao S, Argano C, Natoli G, REPOSI Investigators et al (2019) Sex-differences in the pattern of comorbidities, functional independence, and mortality in elderly inpatients: evidence from the RePoSI Register. J Clin Med 8(1):81PubMedCentral

Titel: Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry
verfasst von: Christiano Argano
Nicola Scichilone
Giuseppe Natoli
Alessandro Nobili
Gino Roberto Corazza
Pier Mannuccio Mannucci
Francesco Perticone
Salvatore Corrao
on behalf of the REPOSI Investigators
Publikationsdatum: 27.07.2020
Verlag: Springer International Publishing
Erschienen in: Internal and Emergency Medicine / Ausgabe 2/2021
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02412-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment

Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis

Leadership through ethics: preliminary assessment of an innovative medical ethics education program

Rapidly destructive osteoarthritis of the hip

Diagnostic reasoning in internal medicine: a practical reappraisal: reply